In:
Phlebologie, Georg Thieme Verlag KG, Vol. 51, No. 01 ( 2022-02), p. 37-50
Abstract:
When bridging anticoagulation, the risk of bleeding - compared to the thromboembolic risk - is often underestimated. Bridging is only indicated in case of high (and possibly moderate) thromboembolic risk. When bridging patients with indication for dual antiplatelet therapy, an interdisciplinary case discussion should take place to assess the risk.
Type of Medium:
Online Resource
ISSN:
0939-978X
,
2567-5826
Language:
German
Publisher:
Georg Thieme Verlag KG
Publication Date:
2022